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Pre-eclampsiaAbstract Objectives: To study the changes in serum IL 6 levels in pre-eclamptic patients and to
detect any correlation between these changes and changes in the umbilical artery Doppler velocime-
try.
Methods: In Shatby Hospital, 100 pregnant women, at or beyond 32 weeks were selected and
divided into three groups: group A with severe pre-eclampsia, group B with mild pre-eclampsia,
and group C with normal pregnancy as control. Measurement of maternal serum IL 6 using ELISA
and umbilical artery Doppler velocimetry was done. Kruskal–Wallis, Mann–Whitney U tests, and
Spearman’s rank correlation tests were used.
Results: A statistical significant difference (p< 0.001) was found regarding serum IL-6 level. Using
ROC curve for IL 6 levels, it is suggested that IL 6 of 0.82 ng/dl is a cutoff level to early diagnose
mild pre-eclampsia (with sensitivity 87.5% and specificity 100%). A statistical significant correla-
tion was found between maternal serum IL 6 levels and S/D ratio and RI in severe pre-eclamptic
group (p< 0.05).
Conclusion: Maternal serum IL 6 > 0.82 ng/dl can be implicated as an early laboratory diagnosis
of mild pre-eclampsia. The significant correlation between maternal serum IL 6 levels and Doppler
velocimetry supports both the immunologic and the systemic endothelial dysfunction theories of
pre-eclampsia.
 2016 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pre-eclampsia is a systemic disorder unique to pregnancy
occurring in 4–8% of pregnant women. It is characterized by
new onset of hypertension and proteinuria after 20 weeks of
gestation.1 There is widespread belief that reduced uteropla-
cental perfusion is the central pathophysiologic process
36 M.Y. Anwer et al.involved in the development of preeclampsia. This reduced
perfusion results from shallow trophoblast invasion with
incomplete endovascular alteration, thereby inhibiting essen-
tial morphological changes of the maternal uterine vasculature
needed to reform the spiral arterioles into low-resistance ves-
sels.2,3 This inadequate trophoblast invasion may result from
decreased expression of human leukocyte antigen-G (HLA-
G) leading to an abnormal interaction with decidual natural
killer (NK) cells, which are believed to play a major role in
these processes through the production of immuno-
regulatory cytokines and angiogenic factors. More recently,
the theory of deficient trophoblastic invasion has been dis-
puted on the basis of evidence that failure to remodel the uter-
ine arteries is also associated with intra-uterine growth
restriction, where no signs of hypertension and proteinuria
are observed.4 Two theories have highlighted the ‘‘excessive
inflammation” and the angiogenic imbalance” theories as the
cause of pre-eclampsia.5 Evidence of inflammation theory
includes elevated inflammatory cytokines and uncontrolled
increased activation of the complement system.6 Macrophages,
neutrophils, and T lymphocytes of the T helper (Th-1) subset
are the predominant cell types mediating the inflammatory cas-
cade in pre-eclamptic women. Pro-inflammatory cytokines
such as IL-6 and TNF alpha interact with important blood
pressure regulatory systems such as the renin–angiotensin sys-
tem, sympathetic nervous system and endothelial factors.7 IL-6
is a pro-inflammatory cytokine produced by mononuclear
phagocytes, endothelial cells, fibroblasts and T cells, expressed
in the reproductive tract and gestational tissues and exerts reg-
ulatory functions in embryo implantation and placental devel-
opment, as well as the immune adaptations required to tolerate
pregnancy.8,9
IL-6 may increase the permeability of endothelial cells by
changing the cell shape and rearrangement of intracellular
actin fibers.10 The quantitative importance of the renin-
angiotensin system in mediating the effects of IL-6 during
pregnancy is unknown and remains to be an important area
of investigation.
Doppler velocimetric parameters have become established
as the cornerstone mechanism to examine RI, PI, and S/D
ratio of the maternal-fetal circulation. Women developing
pre-eclampsia have significantly altered velocimetric parame-
ters, indicative of high vascular RI, compared with women
with normal uterine perfusion.11
1.1. Objectives
The objectives were to study the changes in serum IL 6 levels in
pre-eclamptic patients of different severity and to detect any
correlation between the changes in the maternal serum IL 6
levels and changes in the umbilical artery Doppler velocimetry
in pre-eclamptic patients.
1.2. Methods
100 pregnant women, at or beyond 32 weeks of gestation (32–
40 weeks) were selected from the out-patient ante-natal clinic
and from the inpatient pre-eclamptic unit in Shatby Maternity
University Hospital. Pre-eclampsia was diagnosed according
to the American college of Obstetricians and Gynecologists
in its last version, de novo arterial hypertension, after 20thweek of gestation, with systolic blood pressure >140 mmHg
or diastolic blood pressure >90 mmHg, in two separate mea-
surements, at least 4 h apart. Blood pressure was measured
with the pressure cuff placed on the left arm at the heart level
in sitting position. In addition, the presence of proteinuria of
more than 300 mg/L in a random sample is the other essential
finding to fulfill the diagnosis.
1.3. Exclusion criteria
Multiple pregnancy, pregnancy complicated with diabetes mel-
litus or thyrotoxicosis or pyelonephritis, hypertension diag-
nosed before 20th week of gestation have been excluded.
Patients with chronic inflammatory diseases (e.g. systemic
lupus erythromatosis, rheumatoid arthritis, inflammatory
bowel disease) or with acute inflammatory diseases (e.g. tonsil-
litis, urinary tract infections) and pregnancy before 32 weeks of
gestation, have been excluded.
The research protocol was approved by our institutional
Ethics Committee before the study began. A Written informed
consent for participation in the study was taken from all
recruited women.
Patients were divided into three groups: group A (40
patients) with severe pre-eclampsia, group B (40 patients) with
mild pre-eclampsia, and group C (20 pregnant women) with
normal pregnancy as control.
Blood samples were taken from all included women for
testing serum IL-6 levels. Umbilical artery Doppler velocime-
try was done to all cases to measure S/D ratio, Pulsatility index
PI, and Resistance index RI.
1.4. Sample collection and biochemical analysis
Blood samples were drawn from an ante-cubital vein into
EDTA tubes in all patients. All collected blood samples were
immediately centrifuged at 4000 rpm and +4 C for 10 min
and then the collected sera were transferred to Eppendorf
tubes and kept at 70 C until they were analyzed. IL-6 levels
were determined using Enzyme-linked immunosorbent Assay
ELISA according to the manufacturer’s instructions. Intra
and inter assay coefficients of variation ranged from 3% to
7%.
1.5. Statistical analysis
Mean and standard deviation were used to describe numerical
variables. Kolmogorov–Smirnov test was used to evaluate the
distribution pattern of the data. Kruskal–Wallis test was used
for comparison between 3 groups. Mann–Whitney U test was
used for comparison between two groups.
The ability of IL-6 concentrations to discriminate between
pre-eclamptic and non-pre-eclamptic pregnancies was quanti-
fied by using the area under the receiver operating characteris-
tic (ROC) curve. This area is a suitable measure to summarize
the discriminative power of a value and can range from 0.5 (no
discrimination) to 1.0 (perfect discrimination). A value of 0.7–
0.8 is considered to represent reasonable discrimination, and a
value of >0.8 is good discrimination. When the ROC curve is
plotted with 1-specificity on the abscissa and the corresponding
values for sensitivity on the ordinate the point of the ROC
curve closest to the upper left corner of the coordinate system
Serum IL 6 and umbilical artery Doppler indices 37(where sensitivity and specificity equal 1) represents the best
cutoff value. Spearman’s rank correlation tests were used for
the correlation between serum levels of IL-6 and umbilical
artery Doppler indices. Statistical software program SPSS
was used.
2. Results
No statistical significant difference was found between the
three groups as regards age, BMI, gravidity and parity.
Regarding serum level IL-6, it was higher in group A (sev-
ere pre-eclampsia), than group B (mild pre-eclampsia) and
group C (control group) with statistical significant difference.
It was statistically significantly higher in group B than group
C as in Table 1.
On comparing the RI in the three groups, there was statis-
tical significance difference between severe pre-eclampsia
(Group A) and both mild pre-eclampsia (Group B) and con-
trol group (Group C). The mean was 0.59 ± 0.05 in control
group, 0.7 ± 0.05 in group B and 0.81 ± 0.04, as in Table 2.
On comparing between the changes in maternal serum IL 6
levels and umbilical artery Doppler indices in the three groups,Table 1 Comparison between the different studied groups accordin
Control (Group C) Mild PET (
IL 6
Range 0.62–0.82 0.75–1.18
Mean ± SD 0.71 ± 0.06 0.97 ± 0.14
Median 0.72 0.97
p1
MWp< 0.00
p2
p1: p value between control and each other group.
p2: p value between Mild PET and severe PET group.
KWp: p value for Kruskal Wallis test between the three studied groups.
MWp: p value for Mann–Whitney U test.
* Statistically significant at p 6 0.05.
Table 2 Comparison between the different studied groups accordin
Control Mild PET
RI
Range 0.52–0.66 0.62–0.82
Mean ± SD 0.59 ± 0.05 0.70 ± 0.0
Median 0.58 0.69
p1
LSDp< 0.0
p2
PI
Range 0.74–1.17 0.74–1.67
Mean ± SD 0.94 ± 0.16 1.04 ± 0.2
Median 0.93 0.98
p1
MWp= 0.0
p2
p1: p value between control and each other group.
p2: p value between Mild PET and severe PET group.
p: p value for test (ANOVA).
LSDp: p value of Post Hoc test (LSD).
KWp: p value for Kruskal Wallis test between the three studied groups.
MWp: p value for Mann–Whitney U test.
* Statistically significant at p 6 0.05.there was a statistical significant correlation between (IL 6 and
S/D ratio) and (IL6 and RI) in group A (severe pre-eclampsia).
No statistical significance relation was found between IL6 and
RI, PI, S/D in both mild pre-eclampsia group B and control
group C as in Table 3, and Fig. 1 presents the correlation
between IL6 and RI.
The ability of IL-6 concentrations to discriminate between
pre-eclamptic and non-pre-eclamptic pregnancies was quanti-
fied by using the area under the receiver operating characteris-
tic (ROC) curve. The study concluded a cutoff level of
>0.82 ng/dl to early diagnose pre-eclampsia, with a sensitivity
of 87.5%, 100% specificity, 90% accuracy, 100% positive pre-
dictive value and 66.67% negative predictive value (Table 4
and Fig. 2).
3. Discussion
The exact pathophysiologic events leading to the development
of pre-eclampsia are unknown. It seems that abnormal activa-
tion of the immune system plays a vital role in the etiology of
this systemic disorder. Inflammatory cytokines are known to
be potent activators of the vascular endothelium and proposedg to serum IL6.
Group B) Severe PET (Group A) KWp
1.43–1.79 <0.001*
1.67 ± 0.09
1.69
1* MWp< 0.001*
MWp< 0.001*
g to RI and PI.
Severe PET Test of sig
0.73–0.86 p< 0.001*
5 0.81 ± 0.04
0.82
01* LSDp< 0.001*
LSDp< 0.001*
1.54–1.99 KWp< 0.001*
2 1.78 ± 0.13
1.80
65 MWp< 0.001*
MWp< 0.001*
Table 3 Correlation between IL6, PI, S/D ratio and RI in the
three studied groups.
IL6
Control Mild PET Severe PET
PI Rho 0.416 0.081 0.264
p 0.068 0.619 0.100
S/D ratio Rho 0.137 0.066 0.377*
p 0.564 0.686 0.017
RI* r 0.133 0.085 0.346*
p 0.577 0.601 0.029
rho (q): Spearman coefficient.
r: Pearson coefficient.
RI*: The correlation was done after logarithmic normalization of
IL6.
* Statistically significant at p 6 0.05.
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Figure 1 Correlation between IL6 and RI in the three studied
groups.
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Figure 2 ROC curve for IL6.
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Little is known about the relationship between the severity
of inflammation and the severity of pre-eclampsia due to insuf-
ficient reports investigating this matter.13,14
In our study, serum IL 6 levels were higher in women with
pre-eclampsia (mild and severe) than control group (nor-
motensive) and were higher in severe pre-eclamptic patients
than in mild pre-eclamptic patients. In a review of the current
literature, conflicting results are found. Many studies, match
with our results, showing IL-6 level significantly higher in
pre-eclamptic patients versus control.15–19 On the other hand,
other studies didn’t manage to identify increased maternal
serum level of IL 6 in pre-eclamptic patients.20–22 Moreover,
some studies23,24 show contradictory results. For example, aTable 4 Agreement (sensitivity, specificity and accuracy) for IL6.
Control Cases Sensitivity
IL6 60.82 20 10 87.50
>0.82 0 70study by Wang et al.,23 demonstrated elevated maternal
soluble group sgp130 and IL-6 levels and reduced sgp130
and SOCS-3 expression in women complicated with pre-
eclampsia, and another in vitro study by Zhao et al.,24 in which
soluble IL-6 receptor and sgp 130 production under hypoxic
effect by placentae were determined by immune-
histochemical staining and western blot, stated that IL-6
production was significantly reduced by both normal and
pre-eclamptic placental tissue.
Among the given explanations of the literature variation in
IL-6 levels among pre-eclamptic women was the presence of
underlying maternal infections, stating that a significant subset
of cases of preeclampsia is associated with underlying maternal
infections that are a source of these proinflammatory
cytokines.25 In our study, any women with chronic or acute
inflammatory disease was excluded from the study. Also, dif-
ference in gestational age was another explanation. In our
study, all phlebotomies were performed at or beyond 32 weeks
of gestation. Another given explanation was the difference in
the value of inter-assay coefficient of variation.
The variation in the literature is not only limited to the
raise, decrease or equality of IL-6 levels among pre-eclamptic
and non-pre-eclamptic women as mentioned before, and it
extends to involve the actual levels estimated in the different
studies. In a study by Olusi et al.,26 estimated IL-6 was 60.0
± 13.7 pg/ml and 158.0 ± 35.4 pg/ml in pre-eclampsia and
normal pregnancy respectively (equivalent to 6.0 ± 1.37 ng/dl
and 15.8 ± 3.54 ng/dl). In another study, the values were
55.7 ng/dl and 44.3 ng/dl in pre-eclamptic and normal preg-
nancy respectively.27 In a third study,23 IL-6 was 12.57Specificity PPV NPV Accuracy
100.0 100.0 66.67 90.0
Serum IL 6 and umbilical artery Doppler indices 39± 2.78 pg/ml and 4.44 ± 1.19 pg/ml in pre-eclamptic and nor-
mal pregnancy respectively (equivalent to 1.25 ± 0.27 ng/dl
and 0.44 ± 0.11 ng/dl) in pregnant women beyond 34 weeks
of gestation. These values are near to those found in this study.
Although, through statistical analysis of our results using
ROC curve, a cutoff level of >0.82 ng/dl was elicited as a dis-
crimination between normal women and those with pre-
eclampsia, the result can’t be generalized due to the wide vari-
ations elicited before. Whether the gestational age, the value of
inter-assay coefficient of variation, or the different racial back-
ground of the participant women involved in the different car-
ried studies, further global studies are needed to clarify this
point.
The second objective of our study was to correlate between
the IL-6 level as a marker of inflammation and the severity of
pre-eclampsia using umbilical artery Doppler indices, aiming
to determine the clinical utility of IL-6 measurement in clinical
practice. A significant correlation was found between (IL-6
and S/D) and (IL-6 and RI) in women with severe pre-
eclampsia. This study was carried on women with the estab-
lished pre-eclampsia and it is not possible to determine
whether the increased concentrations of IL-6 was a cause or
consequence of the disease. But, an in vitro study28 concluded
that augmented expression of decidual IL-6 may play a causa-
tive role in the pathogenesis of pre-eclampsia acting as a key
source of circulating factor, as the locally elevated expression
promotes excessive decidual macrophages implicated in shal-
low extra-villous trophoblast invasion of the decidua.
4. Conclusion
Until now, women with pre-eclampsia are evaluated according
to the clinical findings. But, we should consider that women
with clinically mild pre-eclampsia may turn into severe dis-
ease.29 Currently, there was not a standardized effective
method to determine this risk. IL-6 may be a successful marker
for this issue, and the detection of a cutoff level in our study
may be a starting point for further prospective studies, in
which serial measurement of IL-6 is done for women who pro-
gress into pre-eclampsia of varying severity. But still, more glo-
bal studies to standardize the values are needed. The
significant correlation between maternal serum IL 6 levels
and Doppler velocimetry, in this study, supports both the
immunologic and the systemic endothelial dysfunction theories
of pre-eclampsia.
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